methoxy-morpholinyl-doxorubicin has been researched along with Glioblastoma with Sarcomatous Component in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lu, H; Waxman, DJ | 1 |
1 other study(ies) available for methoxy-morpholinyl-doxorubicin and Glioblastoma with Sarcomatous Component
Article | Year |
---|---|
Antitumor activity of methoxymorpholinyl doxorubicin: potentiation by cytochrome P450 3A metabolism.
Topics: Animals; Antineoplastic Agents; Aryl Hydrocarbon Hydroxylases; Cell Line, Tumor; Coculture Techniques; Cytochrome P-450 CYP3A; Doxorubicin; Gliosarcoma; Half-Life; Kinetics; Male; Microsomes, Liver; Oxidoreductases, N-Demethylating; Prodrugs; Rats; Rats, Sprague-Dawley | 2005 |